Literature DB >> 23023379

Monocyte expression of Toll-like receptor-4 in patients with stable angina undergoing percutanoeus coronary intervention.

Bahador Bagheri1, Bahram Sohrabi, Aliakbar Movassaghpur, Simin Mashayekhi, Afagh Garjani, Mehriar Shokri, Mohammad Noori, Alireza Garjani.   

Abstract

BACKGROUND: Toll like receptors (TLRs) are well recognized players in inflammatory conditions. Among them TLR-4 is involved in chronic inflammatory processes such as formation of atherosclerotic plaques.
OBJECTIVE: The present study was aimed to examine the effects of percutanoeus coronary intervention (PCI) as a revascularization method on monocyte expression of hTLR-4 and on the serum levels of two proinflammatory cytokines (TNF-α and IL-1β).
METHODS: Blood samples were obtained from 41 patients with stable angina who were candidates for PCI. The samples were collected immediately before and 2h and 4h after PCI. The expression of hTLR-4 on CD14+ monocytes and the serum levels of TNF-α and IL-1β were measured using flowcytometry and ELISA techniques, respectively.
RESULTS: By comparing the frequency of circulating hTLR-4+/CD14+ monocytes at different time points, it was observed that PCI procedure up regulates the monocyte expression of hTLR-4 (p<0.05). The increase in expression was associated with the elevation of the serum levels of proinflammatory cytokines (p<005). There was a significant correlation between monocyte expression of hTLR-4 and serum levels of TNF-α and IL-1β only before PCI. In spite of parallel increase in the serum levels of proinflammatory cytokines and the monocyte expression of hTLR-4, the correlation did not attain a significant level after PCI intervals.
CONCLUSION: PCI is positively associated with an increase in the monocyte expression of hTLR-4. It is also associated with the elevation in the serum levels of proinflmmatory cytokines. These findings suggest that hTLR-4 monocyte expression may be used as a potential prognostic tool in patients with stable angina undergoing PCI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23023379     DOI: IJIv9i3A1

Source DB:  PubMed          Journal:  Iran J Immunol        ISSN: 1735-1383            Impact factor:   1.603


  4 in total

1.  Hydrocortisone reduces Toll-like receptor 4 expression on peripheral CD14+ monocytes in patients undergoing percutaneous coronary intervention.

Authors:  Bahador Bagheri; Bahram Sohrabi; Ali Akbar Movassaghpour; Simin Mashayekhi; Afagh Garjani; Mehriar Shokri; Masoud Pezeshkian; Alireza Garjani
Journal:  Iran Biomed J       Date:  2014

2.  Everolimus-Eluting Stents Reduce Monocyte Expression of Toll-Like Receptor 4.

Authors:  Mehriar Shokri; Bahador Bagheri; Alireza Garjani; Bahram Sohrabi; Afshin Habibzadeh; Babak Kazemi; Ali Akbar Movassaghpour
Journal:  Adv Pharm Bull       Date:  2015-12-31

3.  Effect of A-769662, a direct AMPK activator, on Tlr-4 expression and activity in mice heart tissue.

Authors:  Maryam Rameshrad; Nasrin Maleki-Dizaji; Hamid Soraya; Negisa Seyed Toutounchi; Abolfazl Barzegari; Alireza Garjani
Journal:  Iran J Basic Med Sci       Date:  2016-12       Impact factor: 2.699

4.  MicroRNA-421 improves ischemia/reperfusion injury via regulation toll-like receptor 4 pathway.

Authors:  Lin-Lin Guo; Ming-Lei Guo; Jian Yao; Yun-Qi Weng; Xue-Zhi Zhang
Journal:  J Int Med Res       Date:  2019-12-18       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.